[HTML][HTML] Cardiovascular-pulmonary interaction in chronic obstructive pulmonary disease with special reference to the pathogenesis and management of cor pulmonale

RA Matthay, MS Niederman, HP Wiedemann - Medical Clinics of North …, 1990 - Elsevier
Chronic obstructive pulmonary disease (COPD), which refers here to a group of diseases
that have in common the physiologic defect of airway obstruction, is often associated with …

Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate

MJ KROWKA, DA CORTESE - Mayo Clinic Proceedings, 1987 - Elsevier
Severe hypoxemia associated with chronic liver disease is an uncommon disorder most
likely due to an intrapulmonary vascular abnormality that has characteristics of both …

Cor pulmonale in chronic obstructive pulmonary disease: circulatory pathophysiology and management

HP Wiedemann, RA Matthay - Clinics in chest medicine, 1990 - Elsevier
The development of pulmonary hypertension and right ventricular failure in COPD patients
signals a poor prognosis. In hypoxic patients, long-term oxygen therapy prolongs life and …

Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica

T Montemayor, I Alfajeme, C Escudero, J Morera… - Archivos de …, 1996 - Elsevier
Las recomendaciones sobre diagnóstico y manejo de la enfermedad pulmonar obstructiva
crónica (EPOC) se confeccionaron hace casi 5 años, siendo publicadas poco después …

Comparison of the effects of intravenous almitrine and positive end-expiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome

JF Prost, P Desche, F Jardin… - European Respiratory …, 1991 - Eur Respiratory Soc
The effects of almitrine on pulmonary gas exchange and haemodynamics were compared to
those of positive end-expiratory pressure (PEEP) in 10 patients with a severe adult …

Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease

BR Winkelmann, TH Kullmer, DG Kneissl, D Trenk… - Chest, 1994 - Elsevier
Study objective: Assessment of acute and chronic effects of low-dose almitrine bismesylate
(AB) in stable chronic obstructive pulmonary disease (COPD). Study design: Oral …

Altering ventilation-perfusion relationships in ventilated patients with acute lung injury

SE Sinclair, RK Albert - Intensive care medicine, 1997 - search.proquest.com
Since its description by Ashbaugh and Petty in 1967, the acute respiratory distress
syndrome (ARDS) has been a major research focus in pulmonary and critical care medicine …

The heart in the stable COPD patient

TL Lee-Chiong, RA Matthay - LUNG BIOLOGY IN HEALTH …, 2002 - api.taylorfrancis.com
The right ventricle lies at the interface of the pulmonary and systemic circulation, thus at the
crossroads of the lungs and the heart. Chronic obstructive pulmonary disease (COPD) can …

Almitrine bismesylate

PD Smith, VP Gotz, GG Ryerson - Drug intelligence & clinical …, 1987 - journals.sagepub.com
Almitrine bismesylate is a pharmacologically unique respiratory stimulant. It enhances
respiration after both acute and chronic administration by acting as an agonist of peripheral …

Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia

J Saas-Torres, C Domingo, A Moron, M Rue… - Respiratory …, 2003 - Elsevier
Background: Almitrine bismesylate (AB) is a peripheral chemoreceptor agonist which is
believed to improve oxygenation of COPD patients with chronic hypoxaemia, probably by …